10/13/2026
🚀🔥 Advancing Cancer Immunotherapy with mRNA-LNP Technology!
New research highlights the potential of intratumoral EpCAM BiTE, IL-12, and GM-CSF mRNA-LNPs to inhibit tumor growth in both locally treated and distant untreated tumors.
The study demonstrates promising antitumor activity in preclinical pancreatic and ovarian cancer models, offering new insights into mRNA-based cancer immunotherapy.
🔬📖 Explore the research and its potential applications in cancer immunotherapy!
Read Proc Natl Acad Sci U S A. 2026 Sep 8;123(36):e2616059123 publication. 👉🔗 🔬 learn more: https://pubmed.ncbi.nlm.nih.gov/42696537/